Abstract
The effect of low levels of added lymphocytosis-promoting factor (LPF) on the ability of several antigenic preparations isolated from Bordetella pertussis and other bacteria to protect mice against intracerebral infection with B. pertussis was examined. LPF was found to enhance the protective activities of filamentous hemagglutinin, 22S antigen, and fimbriae isolated from B. pertussis. Outer membrane protein preparations from phase I B. pertussis which had LPF removed by haptoglobin affinity columns or inactivated by glutaraldehyde, sodium dodecyl sulfate, or Formalin had reduced protective activities but were made fully protective by the readdition of LPF. Similarly, outer membrane protein preparations from Bordetella bronchiseptica, Bordetella parapertussis, or phase IV B. pertussis lacking LPF were protective only when low levels of LPF were added to the preparations. Outer membrane protein preparations from Neisseria gonorrhoeae or Escherichia coli were nonprotective even in the presence of added LPF. The purified LPF by itself was nonprotective unless treated with glutaraldehyde. LPF that had been detoxified with glutaraldehyde was, however, ineffective at enhancing the protective activity of antigenic preparations. The synergistic effect of LPF is discussed in relation to its known biological properties.
MeSH Terms
Animals
Antigens, Bacterial/immunology
Bacterial Toxins/immunology
Bordetella pertussis/immunology
Glutaral
Immunity
Mice
Pertussis Toxin
Pertussis Vaccine/immunology
Virulence Factors, Bordetella
Whooping Cough/prevention & control
Chemicals
Antigens, Bacterial
Bacterial Toxins
Pertussis Vaccine
Virulence Factors, Bordetella
Pertussis Toxin
Glutaral
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Robinson A
Irons L I
References (15)
15 references, click to expand
-
Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.
J Hyg (Lond). 1982 Jun;88(3):475-86
PMID: 6282959
-
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.
Infect Immun. 1981 Apr;32(1):243-50
PMID: 6260681
-
Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.
Infect Immun. 1974 May;9(5):801-10
PMID: 4363229
-
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.
Infect Immun. 1982 Sep;37(3):1278-81
PMID: 6127315
-
Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
Infect Immun. 1983 Feb;39(2):590-8
PMID: 6299946
-
The effects of Bordetella pertussis vaccine on cerebral vascular permeability.
Br J Exp Pathol. 1976 Dec;57(6):653-62
PMID: 12780
-
Stimulation of non-specific resistance by heterologous endotoxins and experimental immunity to Bordetella pertussis in mice.
Immunology. 1971 Aug;21(2):313-22
PMID: 4328408
-
Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
J Exp Med. 1976 Jun 1;143(6):1483-502
PMID: 58054
-
Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci.
Infect Immun. 1978 Jan;19(1):320-31
PMID: 415006
-
Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.
Am J Public Health Nations Health. 1947 Jul;37(7):803-10
PMID: 18016555
-
The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.
J Hyg (Lond). 1975 Feb;74(1):85-102
PMID: 163275
-
Mouse or man? Which are pertussis vaccines to protect?
J Hyg (Lond). 1976 Apr;76(2):249-56
PMID: 177701
-
Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
Biochim Biophys Acta. 1979 Sep 29;580(1):175-85
PMID: 232665
-
Biological activities of crystalline pertussigen from Bordetella pertussis.
Infect Immun. 1981 Sep;33(3):820-6
PMID: 6269999
-
Specific lipopolysaccharides of Bordetella.
Biochem J. 1960 Feb;74:398-409
PMID: 14419582